Insider Trades
News
gurufocus.comResults from Incyte's Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progrgurufocus.comJun 13
gurufocus.comIncyte's Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patiegurufocus.comMay 30
seekingalpha.comHeritage Global Inc. (HGBL) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 8
businesswire.comHeritage Global Inc. Reports First Quarter 2026 Resultsbusinesswire.comMay 7
businesswire.comHeritage Global to Announce First Quarter 2026 Results and Host Webcast on Thursday, May 7, 2026businesswire.comApr 7